Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medical_condition
|
| gptkbp:abbreviation |
gptkb:IOP
|
| gptkbp:affects |
aqueous humor dynamics
|
| gptkbp:cause |
vision loss if elevated
|
| gptkbp:component |
eye examination
|
| gptkbp:decreasedIn |
ocular hypotensive drugs
|
| gptkbp:elevatedIn |
ocular hypertension
|
| gptkbp:improves |
steroid use
|
| gptkbp:loweredBy |
beta blockers
alpha agonists carbonic anhydrase inhibitors prostaglandin analogs |
| gptkbp:measuredDuring |
eye screening
|
| gptkbp:measures |
millimeters of mercury
tonometry |
| gptkbp:range |
10-21 mmHg
|
| gptkbp:regulates |
Schlemm's canal
trabecular meshwork |
| gptkbp:relatedTo |
gptkb:glaucoma
|
| gptkbp:riskFactor |
optic nerve damage
|
| gptkbp:bfsParent |
gptkb:IOP
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Intraocular Pressure
|